Chronic Kidney Disease
Healio celebrates Mental Health Awareness Month
With May serving as Mental Health Awareness Month, Healio has collected the top stories in nephrology that discuss mental health, burnout and the mental burden kidney disease can have on patients and providers.
Akebia receives European approval for anemia drug
Akebia Therapeutics Inc. has received approval from the European Commission to market its oral hypoxia-inducible factor prolyl hydroxylase inhibitor Vafseo in Europe, according to a press release.
AKI hospitalization correlates with risk of death, rehospitalization
Patients who experience AKI during hospitalization showed an increased risk for 90- and 365-day all-cause and selected-cause rehospitalization and death following discharge, according to data in the American Journal of Kidney Diseases.
AKI hospitalization correlates with risk of death, rehospitalization
Patients who experience AKI during hospitalization showed an increased risk for 90- and 365-day all-cause and selected-cause rehospitalization and death following discharge, according to data in the American Journal of Kidney Diseases.
Uptake of urine protein assessments low for adults with type 2 diabetes, CKD
Adults with type 2 diabetes, chronic kidney disease or both conditions have high rates of hospital admissions and ED visits due in part to a low uptake of medications and a lack of engagement with routine assessments, researchers reported.
Difelikefalin improves itch in patients with chronic kidney disease
Itch intensity was reduced in patients with chronic kidney disease and moderate to severe pruritus who were treated with oral difelikefalin, according to a study.
Kentucky expands Medigap access to younger patients
The American Kidney Fund has commended Kentucky for enacting H.B. 345, a law that expands Medigap access to some patients who are younger than 65 years, according to the press release.
Investigational treatment reduces hepcidin, potentially beneficial to patients with anemia
AUSTIN, Texas —An investigational treatment, DISC-0974, can reduce hepcidin and elevate iron levels in healthy patients, according to a presenter at the National Kidney Foundation Spring Clinical Meetings.
Obesity, more common now in young patients, adds to the burden of cardiorenal syndrome
The Cover Story this month in Healio/ Nephrology News & Issues focuses on obesity and its relationship to chronic kidney disease and ultimately, cardiovascular disease and death.
Addressing CKD knowledge gap among nurses could improve care in Jamaica
AUSTIN, Texas — In this video, Andrea G. Mignott, DNP, MSc, FNP, RN, discusses the results of her award-winning poster presentation at the National Kidney Foundation Spring Clinical Meetings.